Effectiveness and safety of high and low dose NOACs in patients with atrial fibrillation

Eur J Intern Med. 2021 Jun:88:118-122. doi: 10.1016/j.ejim.2021.01.031. Epub 2021 Feb 18.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Anticoagulants / adverse effects
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Humans
  • Rivaroxaban / therapeutic use
  • Stroke* / drug therapy
  • Stroke* / prevention & control
  • Treatment Outcome
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Warfarin
  • Rivaroxaban